Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a  multimodal treatment setting

ConclusionSBRT ( ±TACE) in highly pretreated HCC is effective and associated with excellent LC and low toxicity. SBRT may be used as definitive or bridging treatment prior to OLT. Patients with multifocal lesions have significantly decreased 1‑ and 2‑year FFHF and OS.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research